Earnings

ANI Pharmaceuticals Q3 Adj. EPS $2.70 Beats $2.18 Estimate, Sales $290.800M Beat $280.196M Estimate

Nov 5, 2026 · 06:53 AM ET· updated 56m ago

ANI Pharmaceuticals (NASDAQ:ANIP) reported quarterly earnings of $2.70 per share which beat the analyst consensus estimate of $2.18 by 23.85 percent. This is a 32.35 percent increase over earnings of $2.04 per share

Why It Matters

ANI Pharmaceuticals made more money than experts predicted this quarter. When a company beats its targets, it shows the business is running stronger than people thought.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

ANIP72.51

+0.86 (+1.20%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.